Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SGEN

Seagen (SGEN) Stock Price, News & Analysis

Seagen logo

About Seagen Stock (NASDAQ:SGEN)

Advanced Chart

Key Stats

Today's Range
$228.74
$228.74
50-Day Range
$228.74
$228.74
52-Week Range
$123.77
$228.96
Volume
86 shs
Average Volume
1.48 million shs
Market Capitalization
$42.93 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter.

SGEN Stock News Headlines

Pfizer raises guidance as COVID franchise drives Q3 beat
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Franklin Biotechnology Discovery C
Pfizer: Turning The Corner (Rating Upgrade)
See More Headlines

SGEN Stock Analysis - Frequently Asked Questions

Seagen Inc. (NASDAQ:SGEN) released its quarterly earnings data on Wednesday, November, 1st. The biotechnology company reported ($1.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.82) by $0.33. The business's revenue for the quarter was up 27.1% on a year-over-year basis.

Seagen subsidiaries include Cascadian Therapeutics.

Based on aggregate information from My MarketBeat watchlists, some other companies that Seagen investors own include NVIDIA (NVDA), Meta Platforms (META), Intel (INTC), Tesla (TSLA), Advanced Micro Devices (AMD), Pfizer (PFE) and QUALCOMM (QCOM).

Company Calendar

Last Earnings
11/01/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SGEN
CIK
1060736
Employees
3,256
Year Founded
1998

Profitability

EPS (Trailing Twelve Months)
($4.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$610.31 million
Net Margins
-32.61%
Pretax Margin
-32.12%
Return on Equity
-28.06%
Return on Assets
-20.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.67
Quick Ratio
2.12

Sales & Book Value

Annual Sales
$2.30 billion
Price / Sales
18.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.10 per share
Price / Book
15.15

Miscellaneous

Outstanding Shares
187,698,000
Free Float
139,084,000
Market Cap
$42.93 billion
Optionable
Optionable
Beta
0.32

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:SGEN) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners